Literature DB >> 3491091

Inducible interleukin-1 gene expression in human vascular smooth muscle cells.

P Libby, J M Ordovas, L K Birinyi, K R Auger, C A Dinarello.   

Abstract

Interleukin-1 (IL-1) mediates many components of generalized host response to injury and may also contribute to local vascular pathology during immune or inflammatory responses. Because altered function of smooth muscle cells (SMC) accompanies certain vascular diseases, we tested whether SMC themselves might produce this hormone. Unstimulated SMC contain little or no IL-1 mRNA. However, exposure to bacterial endotoxin caused accumulation of IL-1 mRNA in SMC cultured from human vessels. Endotoxin maximally increased IL-1 beta mRNA in SMC after 4-6 h. The lowest effective concentration of endotoxin was 10 pg/ml. 10 ng/ml produced maximal increases in IL-1 beta mRNA. Interleukin-1 alpha mRNA was detected when SMC were incubated with endotoxin under "superinduction" conditions with cycloheximide. Endotoxin-stimulated SMC also released biologically functional IL-1, measured as thymocyte costimulation activity inhibitable by anti-IL-1 antibody. Thus, human SMC can express IL-1 beta and IL-1 alpha genes, or very similar ones, and secrete biologically active product in response to a pathological stimulus. Endogenous local production of this inflammatory mediator by the blood vessel wall's major cell type could play an important early role in the pathogenesis of vasculitis and arteriosclerosis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3491091      PMCID: PMC423884          DOI: 10.1172/JCI112732

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  Regulation of tubulin and actin mRNA production in rat brain: expression of a new beta-tubulin mRNA with development.

Authors:  J F Bond; S R Farmer
Journal:  Mol Cell Biol       Date:  1983-08       Impact factor: 4.272

2.  Epidermal cytokines: properties of epidermal cell thymocyte-activating factor (ETAF).

Authors:  D N Sauder
Journal:  Lymphokine Res       Date:  1984

3.  A novel chromatographic procedure for purification of bacterial plasmids.

Authors:  M Bywater; R Bywater; L Hellman
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

4.  Ability of human leukocytic pyrogen to enhance phytohemagglutinin induced murine thymocyte proliferation.

Authors:  L J Rosenwasser; C A Dinarello
Journal:  Cell Immunol       Date:  1981-09-01       Impact factor: 4.868

Review 5.  Control of human lymphocyte proliferation by soluble factors.

Authors:  A L Maizel; L B Lachman
Journal:  Lab Invest       Date:  1984-04       Impact factor: 5.662

6.  Control of biologically active interleukin 2 messenger RNA formation in induced human lymphocytes.

Authors:  S Efrat; R Kaempfer
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

7.  Growth factors from platelets, monocytes, and endothelium: their role in cell proliferation.

Authors:  R Ross; E Raines; D Bowen-Pope
Journal:  Ann N Y Acad Sci       Date:  1982-12-10       Impact factor: 5.691

8.  Cultured human endothelial cells generate tissue factor in response to endotoxin.

Authors:  M Colucci; G Balconi; R Lorenzet; A Pietra; D Locati; M B Donati; N Semeraro
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

9.  Culture of quiescent arterial smooth muscle cells in a defined serum-free medium.

Authors:  P Libby; K V O'Brien
Journal:  J Cell Physiol       Date:  1983-05       Impact factor: 6.384

10.  Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells.

Authors:  M P Bevilacqua; J S Pober; G R Majeau; R S Cotran; M A Gimbrone
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

View more
  59 in total

1.  Heparin/endothelial cell growth supplement regulates matrix gene expression and prolongs life span of vascular smooth muscle cells through modulation of interleukin-1.

Authors:  J Y Hsu; M Y Hsu; T Sorger; M Herlyn; E M Levine
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999 Nov-Dec       Impact factor: 2.416

Review 2.  Interleukin-1, immune activation pathways, and different mechanisms in osteoarthritis and rheumatoid arthritis.

Authors:  B Kirkham
Journal:  Ann Rheum Dis       Date:  1991-06       Impact factor: 19.103

Review 3.  Endovascular laser–tissue interactions and biological responses in relation to endovenous laser therapy.

Authors:  Michal Heger; Rowan F van Golen; Mans Broekgaarden; Renate R van den Bos; H A Martino Neumann; Thomas M van Gulik; Martin J C van Gemert
Journal:  Lasers Med Sci       Date:  2014-03       Impact factor: 3.161

Review 4.  Inflammation in atherosclerosis.

Authors:  Peter Libby
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-09       Impact factor: 8.311

5.  Chlamydia and Lipids Engage a Common Signaling Pathway That Promotes Atherogenesis.

Authors:  Shuang Chen; Kenichi Shimada; Timothy R Crother; Ebru Erbay; Prediman K Shah; Moshe Arditi
Journal:  J Am Coll Cardiol       Date:  2018-04-10       Impact factor: 24.094

6.  Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14.

Authors:  H Loppnow; F Stelter; U Schönbeck; C Schlüter; M Ernst; C Schütt; H D Flad
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

7.  Cell cycle-dependent interleukin 1 gene expression by cultured glomerular mesangial cells.

Authors:  D H Lovett; A Larsen
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

Review 8.  Interleukin-1 and the effects of cyclooxygenase inhibitors on its biological activities.

Authors:  C A Dinarello
Journal:  Bull N Y Acad Med       Date:  1989-01

Review 9.  The role of CD14 and lipopolysaccharide-binding protein (LBP) in the activation of different cell types by endotoxin.

Authors:  R R Schumann; E T Rietschel; H Loppnow
Journal:  Med Microbiol Immunol       Date:  1994-12       Impact factor: 3.402

10.  Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation.

Authors:  Marianne Böni-Schnetzler; Jeffrey Thorne; Géraldine Parnaud; Lorella Marselli; Jan A Ehses; Julie Kerr-Conte; Francois Pattou; Philippe A Halban; Gordon C Weir; Marc Y Donath
Journal:  J Clin Endocrinol Metab       Date:  2008-07-29       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.